Page last updated: 2024-11-02

pargyline and Benign Neoplasms

pargyline has been researched along with Benign Neoplasms in 4 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, B1
Liu, P1
Wu, H1
Xie, X1
Chen, Z1
Zeng, F1
Wu, S1
He, Y1
Zhao, Y1
Wang, L2
Bohrer, LR1
Pan, Y1
Huang, H1
Jeleń, M1
Pluta, K1
Zimecki, M1
Morak-Młodawska, B1
Artym, J1
Kocięba, M1
Kochanowska, I1
Zhu, W1
Lee, CY1
Johnson, RL1
Wichterman, J1
Huang, R1
DePamphilis, ML1

Other Studies

4 other studies available for pargyline and Benign Neoplasms

ArticleYear
A bioorthogonal nanosystem for imaging and in vivo tumor inhibition.
    Biomaterials, 2017, Volume: 138

    Topics: Animals; Antineoplastic Agents; Coumarins; Ferrous Compounds; Fluorescent Dyes; HeLa Cells; Humans;

2017
LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    Oncogene, 2018, 01-25, Volume: 37, Issue:4

    Topics: Animals; Camptothecin; Carcinogenesis; Cell Line, Tumor; Cellular Senescence; Chromatin; Demethylati

2018
Synthesis and biological evaluation of novel propargylquinobenzothiazines and their derivatives as potential antiproliferative, anti-inflammatory, and anticancer agents.
    Journal of enzyme inhibition and medicinal chemistry, 2016, Volume: 31, Issue:sup3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Autoimmune Diseases; Cell Line, Tumo

2016
An image-based, high-throughput screening assay for molecules that induce excess DNA replication in human cancer cells.
    Molecular cancer research : MCR, 2011, Volume: 9, Issue:3

    Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Disulfiram; DNA Replication

2011